A latent Markov modelling approach to the evaluation of circulating cathodic antigen strips for schistosomiasis diagnosis pre- and post-praziquantel treatment in Uganda. by Koukounari, Artemis et al.
Koukounari, A; Donnelly, CA; Moustaki, I; Tukahebwa, EM; Ka-
batereine, NB; Wilson, S; Webster, JP; Deelder, AM; Vennervald,
BJ; van Dam, GJ (2013) A latent Markov modelling approach to the
evaluation of circulating cathodic antigen strips for schistosomiasis
diagnosis pre- and post-praziquantel treatment in Uganda. PLoS
computational biology, 9 (12). e1003402. ISSN 1553-734X DOI:
https://doi.org/10.1371/journal.pcbi.1003402
Downloaded from: http://researchonline.lshtm.ac.uk/4647758/
DOI: 10.1371/journal.pcbi.1003402
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
A Latent Markov Modelling Approach to the Evaluation
of Circulating Cathodic Antigen Strips for
Schistosomiasis Diagnosis Pre- and Post-Praziquantel
Treatment in Uganda
Artemis Koukounari1,2*, Christl A. Donnelly1, Irini Moustaki2, Edridah M. Tukahebwa3,
Narcis B. Kabatereine3, Shona Wilson4, Joanne P. Webster5, Andre´ M. Deelder6, Birgitte J. Vennervald7,
Govert J. van Dam6
1MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom, 2Department of
Statistics, London School of Economics and Political Science, London, United Kingdom, 3 Schistosomiasis Control Initiative at Vector Control Division – Ministry of Health,
Kampala, Uganda, 4Department of Pathology, University of Cambridge, Cambridge, United Kingdom, 5Department of Infectious Disease Epidemiology, Imperial College
London, London, United Kingdom, 6Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands, 7 Section for Parasitology and Aquatic
Diseases, University of Copenhagen, Copenhagen, Denmark
Abstract
Regular treatment with praziquantel (PZQ) is the strategy for human schistosomiasis control aiming to prevent morbidity in
later life. With the recent resolution on schistosomiasis elimination by the 65th World Health Assembly, appropriate
diagnostic tools to inform interventions are keys to their success. We present a discrete Markov chains modelling framework
that deals with the longitudinal study design and the measurement error in the diagnostic methods under study. A
longitudinal detailed dataset from Uganda, in which one or two doses of PZQ treatment were provided, was analyzed
through Latent Markov Models (LMMs). The aim was to evaluate the diagnostic accuracy of Circulating Cathodic Antigen
(CCA) and of double Kato-Katz (KK) faecal slides over three consecutive days for Schistosoma mansoni infection
simultaneously by age group at baseline and at two follow-up times post treatment. Diagnostic test sensitivities and
specificities and the true underlying infection prevalence over time as well as the probabilities of transitions between
infected and uninfected states are provided. The estimated transition probability matrices provide parsimonious yet
important insights into the re-infection and cure rates in the two age groups. We show that the CCA diagnostic
performance remained constant after PZQ treatment and that this test was overall more sensitive but less specific than
single-day double KK for the diagnosis of S. mansoni infection. The probability of clearing infection from baseline to 9 weeks
was higher among those who received two PZQ doses compared to one PZQ dose for both age groups, with much higher
re-infection rates among children compared to adolescents and adults. We recommend LMMs as a useful methodology for
monitoring and evaluation and treatment decision research as well as CCA for mapping surveys of S. mansoni infection,
although additional diagnostic tools should be incorporated in schistosomiasis elimination programs.
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Introduction
Schistosomiasis is a debilitating parasitic disease in tropical and
sub-tropical areas which has recently attracted increased focus and
funding for control through large scale mass drug administration
(MDA) of praziquantel (PZQ) [1]. However the ability of current
control initiatives to operate cost effectively is reduced by technical
limitations of currently available schistosomiasis diagnostics [2,3].
With the recent resolution on schistosomiasis elimination by the
65th World Health Assembly, schistosomiasis diagnostics research
for population-based assessment is critical with careful consider-
ation given to how those tools might be used within disease
elimination programmes [4–6].
At present the World Health Organization (WHO) recom-
mends the Kato-Katz (KK) method as the standard tool for the
qualitative and quantitative diagnosis of Schistosoma mansoni
infection because of its assumed high specificity, relative simplicity
in field conditions and attractive price. WHO also recommends
MDA with PZQ to be delivered to community populations
defined where KK surveys show an estimated prevalence of over
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50% in school-aged children and to be delivered to children aged
6–16 years where the estimated prevalence is between 10% and
50% in this age group. However, it is well known that KK method
from single stool samples, particularly at low infection endemicities
and following PZQ MDA, can underestimate Schistosoma infection
prevalence (and intensities) and thus overestimate cure rates [7–
11], whilst even multiple slides over multiple days of stool sampling
can influence specificity and overestimate prevalence [10–15]. The
necessity for more ‘‘field-applicable’’, sensitive and cost-effective
diagnostics than the KK method, at least for the routine
surveillance of human S. mansoni infection such as that inherent
within mapping of at-risk populations has also been recently
highlighted [16,17]. Even more worrying, in some endemic
regions microscopic stool samples examination is considered too
logistically difficult in terms of personnel available for routine
surveillance and therefore S. mansoni infection remains undetected
and untreated in control programmes [18]. A promising diagnostic
option is a urine strip test for Circulating Cathodic Antigen (CCA)
which is a genus-specific glycan regurgitated by adult schistosome
worms into the blood stream [19]. A number of cross-sectional
studies evaluating CCA accuracy pre-treatment have stressed the
need for further research assessing the potential role of this
diagnostic assay at different stages of schistosomiasis control
programs [15,17,20].
In this study, we assessed for the first time the diagnostic
accuracy of CCA and of double KK faecal slides over three
consecutive days for S. mansoni infection by age group at baseline
and at two follow-up times post treatment which should be viewed
as a proxy for low transmission areas. Because no true gold
standard diagnoses are available, we developed and fitted latent
Markov models (LMMs) to estimate diagnostic test sensitivities and
specificities, the true underlying infection prevalence and the
probabilities of transitions between infected and uninfected states
[21]. LMMs - which are sometimes also referred to as latent
transition models or regime-switching models – are used to
analyze discrete-time longitudinal data where respondent obser-
vations contain measurement error. This approach defines the
true states as categories (latent classes) of a dynamic latent
(unobservable) variable within a statistical model. The Markov
assumption is reflected in the model via transition probabilities
which allow for correlation between a respondent’s true state at
times t21 and t [22].
We analyzed a detailed dataset from a longitudinal cohort living
along the shorelines of Lake Victoria in Uganda who received one
or two doses of PZQ treatment at baseline. We demonstrated how
the use of LMMs allows estimation of the ‘true’ prevalence of S.
mansoni infection over time and the quantification of the additional
benefit of a second PZQ dose in reducing re-infection levels by age
group.
Materials and Methods
Ethics Statement
Ethical clearance was obtained from the Uganda National
Council of Science and Technology and the study was also
presented to the Danish National Committee on Biomedical
Research Ethics in Denmark (Reference Number: UNCST: HS
59). Informed consent was obtained from individual adult
participants but for children the parents or guardians consented
on their behalf. Thereafter, each individual signed a consent form
before any activity started. All information obtained from
participants was kept confidential. Because some of the partici-
pants might have potentially received PZQ treatment recently
through MDA, field survey assistants asked each participant
detailed questions about previous treatment in order to exclude
such individuals ever treated through MDA, although no such pre-
treated individuals were identified in the current study.
Study Design and Population
We conducted our study in Musoli village, Mayuge district at
baseline and nine weeks after treatment during 2005. Participants
of this study were randomly allocated to one or two PZQ (Shin
Poong Pharmaceuticals, Seoul Republic of Korea) doses at
baseline (40 mg PZQ per kg body weight; double treatment
group: two times PZQ 40 mg per kg body weight administered
two weeks apart). The field survey assistants who delivered these
treatments were not aware of the infection status of any
participants at any time. First follow-up data collection was
performed at nine weeks , and hence at a time aimed to assess cure
rates where the risk of any eggs detected occurring as a
consequence of reinfection was minimal. Second follow-up data
collection was performed two years later during 2007. With
regards to treatment after two years, this is part of the National
programme to treat everyone living in an endemic area and thus a
second MDA was offered after two years. The study location was
selected as this is an area of Uganda known for perennial S. mansoni
transmission, situated on the shore of Lake Victoria [23] where the
community population is not targeted by the National Control
Program [24,25]. The community consists primarily of fishermen
and their dependants with the lake being the only source of fresh
water for them. Furthermore, infrequent use and/or availability of
latrines leads to contamination of the lake especially near the
shoreline, where there is underwater vegetation suitable for the
aquatic intermediate host snails to thrive. In addition, only
individuals .6 years of age were enrolled as very often this is the
age from which schistosome-induced morbidity, in general,
becomes evident.
Population Census
Before any data collection took place, trained and experienced
demographers conducted in 2005 a census of the village
Author Summary
Schistosomiasis remains one of the most prevalent
parasitic diseases in developing countries, with Schistoso-
ma mansoni being the most widespread of the human-
infecting schistosomes. For the routine surveillance of
human S. mansoni infection more ‘‘field-applicable,’’
sensitive, and cost-effective diagnostics that replicate
faecal samples over several consecutive days [the Kato-
Katz (KK) method], are needed. We propose a statistical
modelling framework in order to evaluate the diagnostic
performance of the urine strip test for Circulating Cathodic
Antigen (CCA) and single-day double KK measurements
over three consecutive days for the diagnosis of S. mansoni
infection in two different age groups from Uganda pre-
and post- praziquantel (PZQ) treatment. We demonstrate
that CCA is an appropriate tool for mapping surveys of S.
mansoni infection. Our findings should allow for evaluation
of the risk of potential misinterpretation with regards to
diagnosis of S. mansoni infection through CCA or KK in this
endemic setting pre- and post- PZQ treatment as the
numbers and infection intensities are brought down,
bridging existing important gaps in schistosomiasis diag-
nostics research. More generally, the proposed statistical
analysis can reveal important biological insights from other
diseases without gold standard diagnostic tools whenever
longitudinal data are available.
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population. During this process the inhabitants in each household
registered their relation to the head of the household, year of birth,
gender, occupation, duration of residency in the village and tribal
membership.
Sample Size
A stratified random sample for age and sex was then selected
from the census data. Sample size calculations included detection
of a significant difference of cure rates between the two treatment
groups with reference to cure rates obtained along Lake Albert. A
significance level of a=0.05, a power of 90% with a drop-out rate
of 40% over the two years of studies contributed to the calculation
of 552 individuals but at baseline we managed to recruit 446 with
full parasitological and CCA in urine data as described elsewhere
[23,26]. A further six cases were then eliminated from the analysis
presented in this study due to missing data in number of
treatments and their age.
Parasitological and Immunological Diagnosis
Stool samples were collected on three consecutive days from
each member of the cohort and examined for the presence of S.
mansoni ova. Two duplicate slides of each stool sample were
examined using the KK technique at each day. Each slide was
read by two trained microscopists and any discrepancies resolved
before results were recorded as eggs per gram (EPG) faeces. The
results for all six slides were combined for the descriptive results
presented in Table 1 as this is considered the best KK diagnostic
performance scenario [13] while results of two slides of each single
day are combined and incorporated in the statistical models’
derived results (Tables 2A–3B) because in many studies only a
single stool sample is analysed [25,27–29].
Single urine samples were kept cold after collection and after
return to the laboratory at the end of the day aliquoted and stored
frozen. At baseline and nine weeks, CCA urine samples were kept
in a freezer in Uganda for nine months before they were
transferred frozen to Leiden. At the two year follow-up CCA urine
samples were delivered to Leiden within four weeks of collection.
In Uganda, all CCA urine samples were kept at 220 Celsius
degrees. The freezer in which urine was stored was 218 to 220
degrees C. Results should not be affected as the antigen is very
stable and its detection is not influenced by periods of being
frozen, freeze thaw cycles, or even storage for weeks at room
temperature. They were kept frozen during transport to the
Department of Parasitology, in Leiden, The Netherlands, where
the CCA urine assays were performed as previously described
[19,30]. Briefly, for the laboratory-based test, 25 mL of completely
thawed and vortexed urine was added to a tube containing dried
carbon conjugated antibody, along with 75 mL of buffer and
mixed well. Test strips were added, and allowed to develop for
40 minutes. Strips were removed, allowed to dry, and read against
a set of five Quality Control (QC) standards of 0, 10, 100, 1000
and 10 000 ng of semi-purified worm antigen (containing CCA)
per ml negative urine. A score of 0 indicated a negative result; the
0.5 stands for trace, while 1, 2, and 3, indicated that the intensity
of the test line was similar to that of the respective 100, 1000, and
Table 1. 262 descriptive tables for S. mansoni infection as determined by CCA and microscopy over time; sensitivity and
specificity of CCA were estimated assuming that the combination of 6 KK measurements over 3 days is 100% sensitive and 100%
specific.
A: for children (age 7–16)
Baseline 9 weeks 2 years
KK (6 measurements over 3 days)
CCA 2 + 2 + 2 +
2 2 17 39 26 4 7
+ 2 148 17 66 7 101
Empirical CCA diagnostic performance (%) assuming KK (6 measurements over 3 days) as ‘‘the gold standard’’
Sensitivitya 89.7 (84.0 to 93.9)c 71.7 (61.4 to 80.6) 93.5 (87.1 to 97.4)
Specificityb 50.0 (6.8 to 93.2) 69.6 (55.9 to 81.2) 36.4 (10.9 to 69.2)
B: for adolescents and adults (age 17–76)
Baseline 9 weeks 2 years
KK (6 measurements over 3 days)
CCA 2 + 2 + 2 +
2 37 41 124 24 54 29
+ 7 189 32 43 30 80
Empirical CCA diagnostic performance (%) assuming KK (6 measurements over 3 days) as ‘‘the gold standard’’
Sensitivitya 82.2 (76.6 to 86.9) 64.2 (51.5 to 75.5) 73.4 (64.1 to 81.4)
Specificityb 84.1 (69.9 to 93.4) 79.5 (72.3 to 85.5) 64.3 (53.1 to 74.5)
aThis is derived by taking the ratio of ‘‘true positives’’ over the sum of ‘‘true positives’’ and ‘‘false negatives’’. For instance for children at baseline number of ‘‘true
positives’’ is 148 and number of ‘‘false negatives’’ is 17.
bThis is derived by taking the ratio of ‘‘true negatives’’ over the sum of ‘‘true negatives’’ and ‘‘false positives’’. For instance for children at baseline number of ‘‘true
negatives’’ is 2 and number of ‘‘false positives’’ is 2.
c95% Exact binomial confidence intervals are provided in brackets.
General note: Complete case data at each time point are displayed and contributed to the calculations of empirical sensitivities and specificities.
doi:10.1371/journal.pcbi.1003402.t001
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10 000 ng/ml spiked QC samples. Strips were scored in a blinded
fashion by at least two individuals and in case of discrepancies a
third person was consulted to conclude on the score. The
classification of the trace result is decided later (see ‘Model
selection’ section) based on the use of specific latent variable
models. All other positive results (scores 1, 2 and 3) were merged
into one positive category.
Latent Markov Models and Their Application to
Evaluating Diagnostics for S. mansoni Infection
LMM consists of a structural model for the latent infection states
(analogous to the latent classes in Latent Class Analysis) and a
measurement model for the observed indicators (these are the four
diagnostic tools: the average of two KK measurements on three
consecutive days and the CCA), conditional on latent infection
state.
Let Y= (yi1t,…, yiPt) be a response pattern for the i
th individual at
time t on P observed binary indicators (in this study P=4 binary
diagnostic tests) with values ‘0’ and ‘1’ indicating negative and
positive diagnostic test results, respectively.
We assume that for each individual the true underlying infection
state, at each discrete time point t (where t=1,…T and T=3:
baseline, nine weeks and two years) is explained by a latent
categorical variable denoted by C with two latent infection states
(i.e. those with S. mansoni infection and those without).
The responses to the (P6T) y indicators are assumed to be
independent conditional on the latent infection state membership
which in our analysis implies that the results from the four
diagnostics are assumed to be independent conditional on the true
underlying infection state both within and across time points. In
addition, the latent categorical variable Ci,t depends on Ci,t-1 but
not on earlier latent categorical variables, known as the first-order
Markov property. Under these assumptions, the probability of
observing a particular response pattern Y for a randomly selected
individual i is:
P(Yi~yi)~
X2
j1~1
:::
X2
jT i~1
P(Ci,1~j1) P
Ti
t~2
P(Ci,t~jtDCi,t{1~jt{1) P
Ti
t~1
P
P
p~1
rptDjt
(1{yipt)(1{rptDj t)
yipt
where P(Ci,1~j1) represents the baseline infection state preva-
lence at the first time point (i.e. baseline), and
P(Ci,t~jtDCi,t{1~jt{1) represents the transition probability to
latent infection state jt at time t conditional on membership in
latent infection state jt-1 at time t-1. rptDjt represents the diagnostic
specificity for infection when the probability of the p diagnostic test
is negative conditioned on Ci,t representing the ‘Not Infected’
latent state. Similarly, the diagnostic sensitivity for infection of
each of the four diagnostics is obtained when the probability of the
p diagnostic test is positive conditioned on Ci,t representing the
‘Infected’ latent state.
Figure 1 presents our LMM in a path diagram.
Computation
We fitted several LMMs using MPLUS v. 6.1 (Muthe´n &
Muthe´n, Los Angeles) [31] with full information maximum
likelihood in which we assumed that missing data were missing
at random and making maximum use of data from individuals
with incomplete data at the time points under study, for two
different age groups: a) n = 167 children of age 7–16 years old and
b) n = 273 adolescents and adults of age 17–76 years old. It is well
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known that different contact patterns with infected water bodies
and consequently acquired exposure, immunity and susceptibility
to infection might be experienced by different age groups [32].
We thus estimated the following sets of parameters for these two
age groups:
1) Probabilities of positive or negative responses from KK and CCA
diagnostic tests conditional on the latent ‘infection’ state at each
time point (i.e. diagnostic sensitivities and specificities); in latent
variablemodelling literature these are called item response probabilities.
2) Transition probabilities of the latent infection states between
the study time points i.e. from baseline to nine weeks and from
nine weeks to two years.
3) The ‘true’ prevalence of S. mansoni infection at each time point.
Model Selection and Classification of a ‘‘Trace’’ CCA Test
Line
We selected the LMMs that optimally combined goodness of fit
and parsimony as measured using the Akaike Information
Criterion (AIC) and the Bayesian Information Criterion (BIC).
[33] Both AIC and BIC are penalized-likelihood criteria. AIC is
an estimate of a constant plus the relative distance between the
unknown true likelihood function of the data and the fitted
likelihood function of the model, so that a lower AIC means a
model is considered to be better. BIC is an estimate of a function
Table 3. LMM estimated transition probability matrices.
A: for children-n =167
Treatment Interval
Baseline-to-9 weeks
9 weeks
1 PZQ dose 2 PZQ doses
I2 I+ I2 I+
Baseline I2 1.000a 0.000 I2 1.000b 0.000
I+ 0.458 0.542 I+ 0.717 0.283
Non-Treatment Interval
9 weeks-to-2 years
2 years
1 PZQ dose 2 PZQ doses
I2 I+ I2 I+
9 weeks I2 0.437 0.563 I2 0.422 0.578
I+ 0.202 0.798 I+ 0.000 1.000c
B: for adolescents and adults-n=273
Treatment Interval
Baseline-to-9 weeks
9 weeks
1 PZQ dose 2 PZQ doses
I2 I+ I2 I+
Baseline I2 1.000a 0.000 I2 1.000b 0.000
I+ 0.561 0.439 I+ 0.846 0.154
Non-Treatment Interval
9 weeks-to-2 years
2 years
1 PZQ dose 2 PZQ doses
I2 I+ I2 I+
9 weeks I2 0.858 0.142 I2 0.836 0.164
I+ 0.126 0.874 I+ 0.000 1.000c
a, b, cThese parameters were estimated close to 1 or 0 and so in order to avoid numerical instability in the estimation algorithm, MPLUS fixed these automatically to 1 or
0 respectively. Such values should be treated with caution due to computational limitations in these categories during the model estimation.
General note: The displayed results are derived by exploiting in the final LMM the interrelationships between CCA and double Kato-Katz (KK) faecal slides over 3
consecutive days as well as not assuming a gold standard.
doi:10.1371/journal.pcbi.1003402.t003
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of the posterior probability of a model being true, under a
particular Bayesian framework, so that a lower BIC means that a
model is considered to be better. BIC penalizes model complexity
more heavily and thus, whenever there is an inconsistency AIC
indicates a preference for a more complex model than BIC [34].
Both criteria are based on assumptions and asymptotic approx-
imations. Each, despite its heuristic usefulness, has therefore been
criticized as having questionable validity for real-world data
[34,35]. In the current study, we examined AIC and BIC as well
sample-size-adjusted BIC among models that were considered
biologically plausible for the epidemiological settings under study
(given the effect of one and two PZQ doses on schistosomiasis cure
rates within the studied age groups).
We first tested whether the interpretation of a ‘trace’ CCA test
line should be classified as positive or negative as several studies
have reported on the ambiguity of infection status among those
classified as ‘trace’ [16,17,36,37]. For this problem we used a one
factor analysis model [38] on the baseline data, to explore the
interrelationships among the four diagnostic tests for both age
groups, treating the three results of CCA (‘negative’, ‘trace’ and
‘positive’) as nominal (unordered). We plotted the posterior
distribution of the latent variable given the three possible responses
to CCA for children (Figure 2) and adolescents and adults
(Figure 3), after estimating the one factor analysis model. Having
observed the similarities in the posterior distributions for the ‘trace’
and ‘negative’ categories in Figures 2 and 3, we decided to treat
‘negative’ and ‘trace’ CCA as a single ‘negative’ category for the
rest of this analysis. Similar statistical analysis might be useful for
data related to point of care-CCA in order to further validate
results and proceed with generalization of recommendations about
trace results for the CCA in the field.
We subsequently fitted LMMs where we initially tested whether
the item response probabilities (r’s, i.e. the sensitivities and
specificities) assumed to be the same at baseline and two years but
allowed to vary at nine weeks for both KK and CCA tests. In other
words we tested the hypothesis of measurement invariance which
assumes the equality of the parameters of the measurement model
i.e. the conditional item response probabilities for the latent
infection states at the different time points. We did not test for
different r’s at each of the three time points (baseline, nine weeks
and two years) because if they did differ at each time point the
meaning of the latent infection states would have changed over
time making the transition probabilities t’s uninterpretable. The
reason for this is that along with interpreting quantitative change
Figure 1. Latent Markov modelling path diagram. The variables in boxes represent the four observed categorical indicators of the latent
categorical variables C at each time point t. The three arrows between the circled variables indicate the regression model for the latent categorical
variable at time point t on the latent categorical variable at time point t-1.
doi:10.1371/journal.pcbi.1003402.g001
Figure 2. Posterior distributions of latent variables conditioned on the responses of the CCA test for children (n=167). The latent
variable represents a continuum of the infection severity characterized from the left to the right as to low or no infection up to high infection. The
obtained scores in the horizontal axis are linked to ranking and not necessarily to the absolute displayed values.
doi:10.1371/journal.pcbi.1003402.g002
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over time in latent infection state membership (i.e. through the t’s),
it also becomes necessary to interpret change over time in the
meaning of the latent infection state (i.e. which latent infection
state represents the ‘true’ negatives and ‘true’ positives at each
time point).
We also tested whether the provision of one or two PZQ doses
affected the transition probabilities t’s in the non-treatment
intervals (nine weeks and two years) or only in the treatment
interval (baseline to nine weeks) since there might be long-term
benefits of two PZQ doses in the absence of snail control as in this
community. Equal transition probability t’s across each of the
treatment intervals under study was not tested because this was not
consistent with prior knowledge of the MDA impacts.
Although there was information identifying the household of
each individual in the study, there were not enough data within
each of the age groups studied to take into account between-
household variability in the considered models.
Results
The observed numbers of ‘‘true’’ and ‘‘false positives’’ and
‘‘true’’ and ‘‘false negatives’’, and corresponding observed
sensitivity and specificity, for the CCA diagnostic test are
presented assuming, for illustration, the combination of three
duplicate KK measures over the three consecutive days as being
both 100% sensitive and 100% specific (Table 1).
When the sensitivities and specificities of single-day double KK
results were estimated by fitting LMMs, the information criteria
indicated that, for both age groups, the transition probability
matrices [for the baseline-to-nine weeks follow-up (treatment
interval) and for the nine weeks-to-two years follow-up (non-
treatment interval)] depended on the provision of one or two PZQ
doses. Similarly, the measurement invariance hypothesis for CCA
was accepted based on the information criteria; however, the
measurement invariance hypothesis was rejected for KK (i.e. the
diagnostic performance of KK was found to vary over time but that
of CCA was not). For further details on final model selection, see
Table S1. The estimated sensitivities and specificities for CCA and
KK tests, from the best LMM for each age group are presented in
Table 2. Based on these estimates and if one took the crude average
of the estimated sensitivities and specificities of the two diagnostic
measures and time points under examination, CCA overall was
found to be more sensitive but less specific than double KK from a
single faecal sample for both age groups. The sensitivity of double
KK from a single faecal sample was found to be lower at nine weeks
than at baseline and two years for both age groups in all three days
for adolescents and adults and for two of the three days for children.
The estimated transition probabilities between the latent infection
states over time are presented in Table 3. Diagonal elements
represent the probabilities of remaining in the same latent infection
state at time t as at the previous time (t-1). The majority of adolescents
and adults apparently remained, over the non-treatment interval, in
the same latent infection state. Among those infected at baseline in
both age groups, two PZQ doses produced a higher probability of
clearance of infection at nine weeks than just one PZQ dose; for
children these probabilities were 0.717 (2 doses) and 0.458 (1 dose)
(see Table 3A), while for adolescents and adults these probabilities
were 0.846 (2 doses) and 0.561 (1 dose) (see Table 3B).
The S. mansoni prevalence estimate for each time point and each
age group is presented in Figure 4 with 95% confidence intervals.
Following treatment the prevalence of S. mansoni infection decreased
dramatically between baseline to nine weeks for both age groups.
Among children there is a substantial rebound by two years. These
patterns are also reflected in the transition probabilities in Table 3.
Although visual examination of Table 4 superficially suggests
that the LMM estimate conflicts with that obtained based on the 6
KK measurements (assumed positive if one or more of the six
measurements was positive), further calculations are required to
underpin full interpretation of the results.
For instance, for children at baseline, the estimated prevalence
based on the LMM is 92.6%.
One would expect the following percentage of true positives:
92:6%  1{ 1:990ð Þ  1:938ð Þ  1:96ð Þð Þ~
92:6%  0:999975~92:6%
where 0.990, 0.938 and 0.960 are the estimated sensitivities of two
KK measurements from days one, two and three, respectively
Figure 3. Posterior distributions of latent variables conditioned on the responses of the CCA test for adolescents and adults
(n =273). The latent variable represents a continuum of the infection severity characterized from the left to the right as to low or no infection up to
high infection. The obtained scores in the horizontal axis are linked to ranking and not necessarily to the absolute displayed values.
doi:10.1371/journal.pcbi.1003402.g003
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One would expect the following percentage of false positives:
100%  92:6%ð Þ  1{:715  :641  :709ð Þ
~7:4%  0:675005~5:0%
where 0.751, 0.641 and 0.709 are the estimated specificities of two
KK measurements from days one, two and three, respectively.
Thus, based on the estimated sensitivities, specificities and the
assumption that results from days one, two and three, were
independent, conditional on the true status, the LMM predicts
that the estimated prevalence based on 6 KK measurements
would be 97.6% (92.6% true positive and 5.0% false positives).
This is highly consistent with the estimate obtained from the 6 KK
measurements: 97.6%.
For the remaining time points and age groups please see Text
S2 in Supporting information.
Discussion
This study analysed a longitudinal detailed dataset from
Uganda in which one or two doses of PZQ treatment were
provided at baseline using LMM that accounted for the
longitudinal study design and the measurement error in the
diagnostic methods under study. Our primary objective was to
assess the CCA diagnostic accuracy at baseline and at two follow-
up times after treatment but we also evaluate double KK faecal
slides over three consecutive days for S. mansoni infection. To our
knowledge, this is the first study which provides rigorous model-
based diagnostic performance of CCA and single-day double KK
measurements over three consecutive days for the diagnosis of S.
mansoni infection in two different age groups pre- and post- PZQ
treatment.
CCA’s diagnostic performance was found to be constant over
time and overall approximately 90% sensitive but less specific than
single-day double KK faecal slides for S. mansoni infection in both
age groups. Day-to-day variation in faecal egg output among
Schistosoma parasites [7–9] has been shown to be greater [11] and
with lower sensitivity of KK after PZQ treatment [8]. The single-
day double KK sensitivity is likely to depend strongly on the
observed prevalence [8,15,39]. Our study confirmed these findings
and arguments and showed clearly that sensitivity of single-day
double KK was much lower at nine weeks than at baseline and
two years for both age groups in all three days for adolescents and
adults and for two of the three days for children while its specificity
increased after PZQ treatment (Table 2).
These findings bridge existing gaps in schistosomiasis diagnos-
tics research such as for instance the lack of CCA evaluation in
adolescents and adults and the lack for evidence for its capacity to
determine if a person has been cured after treatment, as previously
highlighted [4,17]. The current analysis provides model-based
estimates of sensitivity and specificity and their uncertainties
(through the provision of 95% confidence intervals) without
assuming any gold standard diagnostic test in the statistical
analysis. The exact numbers of false positive and false negative
results are almost always unknown and thus in the current study
we estimated rather than assumed values for the parameters
displayed in Tables 2 and 3 (sensitivities, specificities and transition
probabilities) [40,41]. Without quantification of the uncertainties
regarding the performance of the key diagnostic tests, generaliza-
tion of epidemiological results and development of useful
recommendations for which diagnostics to use and at which
stages of schistosomiasis control are hampered.
This approach evaluates the risk of potential misinterpretation
with regards to diagnosis of S. mansoni infection through CCA or
Figure 4. LMM estimated ‘‘true’’ S. mansoni prevalence for both age groups (ages 7–16 and 17–76) with 95% confidence intervals
over time.
doi:10.1371/journal.pcbi.1003402.g004
Table 4. Estimated S. mansoni prevalences based on 6 KK
measurements and based on the LMM.
Source of the estimate Baseline 9 weeks 2 years
Children
6 KK measurements 97.6 62.1 90.8
Latent Markov model 92.6 38.0 67.9
Adolescents and Adults
6 KK measurements 83.9 30.0 56.5
Latent Markov model 72.9 22.5 31.3
doi:10.1371/journal.pcbi.1003402.t004
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KK in this endemic setting pre- and post- PZQ treatment as the
numbers and infection intensities are brought down [12]. For
instance, results in Table 1 demonstrate that by using 6 KK
measurements over three days as the gold standard (i.e. assuming
100% sensitivity and 100% specificity), the resulting empirical
estimates of CCA sensitivity and specificity are mistakenly shown
to vary over time. We do not expect that the clearance of the
antigen is influenced by treatment. Furthermore, the hypothesis of
measurement invariance was not rejected based on information
criteria for the fitted LMMs (see Text S1 and Table S1 in
Supporting Information).
Glinz et al. 2010 [42] discussed possible reasons for false positive
diagnoses from KK tests. Results from model in Table 2 clearly
indicate that the specificity of single-day double KK measurements
is lower than 100%. This means that despite highly qualified and
skilled co-workers, contamination of stool sieves in the field and data
entry errors cannot completely be avoided. Because our estimated
specificities of single-day double KK measurements were less than
100%, the estimated ‘true’ S. mansoni prevalence (Figure 4) is lower
at each time points than the estimated prevalence obtained
assuming that any individual with positive results on one or more
of the six KK tests conducted over three consecutive days was
infected (Tables 1 and 4 ). This is in accordance with work on
diagnostic performance of KK for animal schistosomiasis infection
[14]. Previous work using stochastic models have demonstrated that
the sensitivity of the KK would vary according to the number of
stool samples provided [7–9] and the ‘true’ S. mansoni prevalence at
baseline can be calculated using the De Vlas pocket chart [8]. For
the children group, the chart is not applicable since the observed
prevalence in this study is beyond the limits where the De Vlas
model is valid and thus we cannot compare it with the estimates of
‘true’ prevalence from our model (Figure 4). For the adolescents and
adults group however estimates of the ‘true’ prevalence (Figure 4)
were not consistent with this chart because it was based on an
assumption of 100% KK specificity.
The estimated transition probability matrices (Table 3) provide
parsimonious yet important insights into the re-infection and cure
rates in the two age groups. The cure rate was higher in
adolescents and adults than in children following treatment. This
can be explained by the fact that those infected in the older age
group had lower burdens than the infected children and would be
therefore more likely to become negative. From an immunological
perspective view, it can be argued that the older age group are
more likely to have developed protective immune response and are
therefore more efficient in affecting and killing the worms [43,44].
The quantification of the additional benefit of a second PZQ dose
in reducing infection levels for both age groups was demonstrated
by higher transition probabilities from infected to non-infected
among those who received two PZQ doses compared to those who
received one PZQ dose within the treatment interval. For the non
treatment interval (i.e. between nine weeks and two years) there
were no differences in reinfection or cure rates among those who
received one or two PZQ doses. As the LMMs are estimated using
an iterative algorithm, at each step of the algorithm, estimated
values very close to 0 or 1 can create estimation instability and
therefore are automatically from MPLUS fixed to 0 and 1
respectively in order to avoid non-convergence of the estimation
algorithm. Consequently, such values should be treated with
caution due to computational limitations in these categories during
the model estimation. Finally, we recognize that the results of this
study depend upon the assumption of conditional independence
assumed by the models fitted here. Once one conditions on the
latent infection state, we believe though that there are good
reasons to assume that KK and CCA are independent as
Schistosoma eggs and antigens are excreted through different routes
in the human body, for instance.
To conclude, in the absence of a diagnostic gold standard this
study has demonstrated that LMMs can be useful for the
evaluation of available diagnostic tools for S. mansoni infection.
More generally, we recommend LMMs to be used for the
evaluation of diagnostic tests of other diseases without gold
standard diagnostic tools whenever longitudinal data are available
as such modelling permits questions about changes in true
infection states and test the measurement invariance hypothesis
of the diagnostic tests of interest over time - making them very
useful tools indeed for control program M&E research [21].
Further work in evaluating the trace result and the ability of CCA
to quantify intensity of infection is also warranted in the M&E of
schistosomiasis control programs and dynamic latent factor models
(such models would assume continuous hypothetical constructs or
typologies-i.e. intensity of infection) might be appropriate statistical
methods for the analysis of relevant data. Similar studies should be
considered at other sites in order to build on our results. We found
that the CCA diagnostic performance remained constant after
provision of PZQ treatment and that the test is overall more
sensitive but less specific than single-day double KK for the
diagnosis of S. mansoni infection. In line with the results from our
study and those of a recent multi-country cross-sectional study
which showed that for lower S. mansoni intensity settings the CCA
sensitivity was demonstrated to be higher than KK [17], we
recommend that CCA to be used for mapping surveys of S. mansoni
infection. As public health measures are aimed at the elimination
of residual foci of schistosomes, data generated using diagnostics
with high specificity will be required to avoid unnecessarily
prolonging MDA and wasting scarce resources [5]. Detection of
parasite-specific DNA [45,46] or circulating anodic antigen in
serum or urine [47] might present alternative opportunities in
schistosomiasis elimination programs and further evaluations of
these diagnostics merit attention.
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